Fact Sheet for Healthcare Providers: Abbott Alinity m SARS-CoV-2 Assay – Abbott Molecular, Inc. | NLM

Disaster Information Management Research Center | NLM

Fact Sheet for Healthcare Providers: Abbott Alinity m SARS-CoV-2 Assay – Abbott Molecular, Inc.

05/11/2020 12:00 AM EDT

Source: U.S. Food and Drug Administration (FDA). Published: 5/11/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Abbott Alinity m SARS-CoV-2 assay, which received an Emergency Use Authorization from the Food and Drug Administration on May 11, 2020. The Abbott Alinity m SARS-CoV-2 assay is authorized for use on respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)